Skip to main content
MainBoardListed
Suraksha Diagnostic Limited Logo

Suraksha Diagnostic Limited IPO

Suraksha Diagnostic Limited IPO

IPO Date :
Issue Price :
Allotment Date :
Listing Date :
List Price :
Lot Size:
Subscription:
Listed Price: ₹ 438.00 (-0.68%)

The public market debut of Suraksha Diagnostic Limited's was completed on 06-12-2024 with its listing on the NSE, BSE exchange. The IPO process raised 1,91,89,330 Shares in total capital, consisting of TBD in new equity and ₹846.25 Cr in existing share sales through the OFS route.

The offering featured a price range of ₹420 to ₹441 and minimum application size of 34 shares. Investor response during the subscription period from 29-11-2024 to 03-12-2024 influenced the final allotment ratios across investor categories.

Final allotment was announced on 04-12-2024, distributing shares to successful subscribers. The listing established a continuous market for the company's shares, enabling liquidity, valuation transparency, and broader investor participation.

Suraksha Diagnostic IPO Details
Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

IPO Reservation
Suraksha Diagnostic IPO Key Performance Indicator
Company Financials ( In Crores )

Suraksha Diagnostic IPO About Company

Suraksha Diagnostic Limited, incorporated on March 15, 2005, is a technology-driven diagnostic chain offering integrated pathology, radiology, and medical consultancy services. The company provides over 2,300 tests across multiple specialties through a network that includes a central reference laboratory, 8 satellite laboratories, and 194 customer touchpoints, comprising 48 diagnostic centers and 146 sample collection centers. Additionally, 43 diagnostic centers house 120 polyclinics staffed by over 750 doctors, providing online and offline consultations. Leveraging advanced technology such as LIMS, RIS, PACS, and ERP systems, Suraksha Diagnostic enhances operational efficiency and reduces turnaround times. The company also offers vaccination services, customized testing packages for early disease detection, and AI-driven digital pathology solutions, with all radiology reports digitally processed to enable seamless reporting across centers.


Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."


Suraksha Diagnostic IPO Strength Factors

  1. Strong Market Position: Leading diagnostics chain in eastern and northeastern India with growth potential in a fragmented market.
  2. Comprehensive Offerings: Integrated pathology, radiology, and medical consultancy services with a wide network of diagnostic and sample collection centers.
  3. Technological Edge: Advanced clinical infrastructure with digital pathology, AI-driven diagnostics, and efficient systems including LIMS, RIS, PACS, and ERP.

Suraksha Diagnostic IPO Risk Factors

  1. Geographic Concentration: Heavy reliance on West Bengal for 95.48% of revenue makes the company vulnerable to regional disruptions affecting operations and financial performance.
  2. Promoter Group Issues: Past suspension of securities of certain Promoter Group members raises reputational concerns and may complicate future capital raising.
  3. Intense Competition: Operating in a competitive diagnostics industry with a modest market share (1.15–1.30% in East India) could restrict growth and profitability.

Suraksha Diagnostic IPO Lead Manager(s)

  • ICICI Securities Limited
  • Nuvama Wealth Management Limited
  • SBI Capital Markets Limited

Suraksha Diagnostic IPO Promoter(s)

  1. Dr. Somnath Chatterjee
  2. Ritu Mittal
  3. Satish Kumar Verma

Suraksha Diagnostic IPO Company Details

Suraksha Diagnostic Limited
Phone:
address:

Suraksha Diagnostic IPO Registrar

Kfin Technologies Limited
Name:
Phone:

Suraksha Diagnostic IPO FAQs